ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1523

Trend Analysis of Lupus Nephritis Flares, Mortality, and Disparities: 2016-2020

Husam El Sharu, East Carolina University, Greenville, NC

Meeting: ACR Convergence 2024

Keywords: Lupus nephritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: SLE – Diagnosis, Manifestations, & Outcomes Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Introduction: In the past decade, the incidence of Lupus Nephritis (LN) flares linked to mortality has generally decreased, though an upward trend has emerged since 2015. However, this trend has not been investigated in the context of the COVID-19 pandemic. Additionally, there is a lack of research addressing disparities in LN during the COVID-19 era. We aim to examine the trends of LN flares, hospitalizations, and disparities during the most recent years to identify those gaps in the literature. 

Methods: We conducted a retrospective analysis using the National Inpatient Sample (NIS) database from 2016 to 2020. LN hospitalizations were analyzed and stratified by year using the International Classification of Diseases – 10 Clinical Modification (ICD-10-CM) codes. The primary outcome was the trends of mortality among patients with LN. Secondary outcomes included LN flares/hospitalizations, disparities, length of stay, and total hospital charge.  Student’s T-test, multivariate logistic regression, and linear regression were used.

Results: Between 2016 and 2020, there were 865,670 hospitalizations with Systemic Lupus Erythematosus (SLE). Of patients with SLE, 125,680 (14.5%) patients had LN. Among patients with LN, 32,915 (26.18%) were admitted to the hospital with an LN flare. Overall, LN flares decreased by 56% from 2016 to 2020 (p< 0.001). However, the adjusted Odds Ratio (aOR) of mortality has been increasing since 2016, with a statistically significant difference in 2020 compared to 2016 (aOR for mortality in 2020 was 2.61 CI: 1.04-6.55, p=0.04). The length of stay for patients with LN was 6 days with no change over time, but the hospital charges gradually increased from 65,000$ in 2016 to 82,822$ in 2020. The mean age for patients who died with LN was 36.2, with no change over time. Women accounted for 81% of all deaths, and the African American population accounted for 42% of deaths. However, there was no statistically significant change in those trends over time.

Conclusion: Over time, patients with LN have fewer flares, but patients who are admitted to the hospital have increased odds of mortality, especially in the year 2020 with the strike of COVID-19.

Supporting image 1

The figure highlights the hospitalization rates and the aOR of mortality among patients with LN flares.


Disclosures: H. El Sharu: None.

To cite this abstract in AMA style:

El Sharu H. Trend Analysis of Lupus Nephritis Flares, Mortality, and Disparities: 2016-2020 [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/trend-analysis-of-lupus-nephritis-flares-mortality-and-disparities-2016-2020/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/trend-analysis-of-lupus-nephritis-flares-mortality-and-disparities-2016-2020/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology